Isolation of epithelial cells form fresh PDAC patient tissues and normal pancreas for analysis of transcriptome and whole genome methylome. (c): Elisa Espinet

In a study led by HI-STEM researcher Elisa Espinet, HI-STEM researchers teamed up with an interdisciplinary group of clinicians, bioinformaticians and biomedical researchers to shed more light on the reasons for the heterogenous aggressiveness of different pancreatic tumors.

They were able to define two differently aggressive molecular subtypes of pancreatic carcinoma based on the DNA-methylome of the tumor cells, providing new insights into the origin of the tumors. In the more aggressive group of tumors, a phenomenon known as "viral mimicry" leads to a cancer-promoting inflammatory reaction. This could possibly be the basis for the development of a targeted, subtype-oriented therapy. The results have now been published in the journal Cancer Discovery.

 Read more:

  • Original Publication: Elisa Espinet, Zuguang Gu, Charles D. Imbusch, Nathalia A. Giese, Magdalena, Büscher, Mariam Safavi, Silke Weisenburger, Corinna Klein, Vanessa Vogel, Mattia Falcone, Jacob Insua-Rodríguez, Manuel Reitberger, Vera Thiel, Steffi O. Kossi, Alexander Muckenhuber, Karnjit Sarai, Alex YL Lee, Elyne Backx, Soheila Zarei, Matthias M. Gaida, Manuel Rodríguez-Paredes, Elisa Donato, Hsi-Yu Yen, Roland Eils, Matthias Schlesner, Nicole Pfarr, Thilo Hackert, Christoph Plass, Benedikt Brors, Katja Steiger, Dieter Weichenhan, H. Efsun Arda, Ilse Rooman, Janel L. Kopp, Oliver Strobel, Wilko Weichert, Martin R. Sprick* and Andreas Trumpp*: Aggressive PDACs show hypomethylation of repetitive elements and the Execution of an intrinsic IFN program linked to a ductal Cell of origin Cancer Discovery 2020, DOI: 1158/2159-8290.CD-20-1202
  • DKFZ Press Release (German Version)
  • Twitter Thread by Elisa Espinet summarizing the results: https://twitter.com/ElisaEspinet/status/1316781872303820800
  • Altmetric Page for the Article: https://www.altmetric.com/details/92452310
Phd Defense of Pia Sommerkamp (middle) with her supervisors Andreas Trumpp and Nina Cabezas-Wallscheid

Pia Sommerkamp, who carried out her PhD at HI-STEM and the Division of Stem Cells and Cancer at the DKFZ until July 2019, has been awarded the Wilma-Moser Prize of Heidelberg University. The award annually honors the youngest female doctoral candidate finishing the PhD with distinction (“summa cum laude”) within the faculties of Medicine and Natural Sciences, Mathematics, and Computer Sciences. Pia defended her PhD in July 2019 and is currently continuing her work as a Postdoc at HI-STEM. 

As part of her PhD, which was jointly supervised by Nina Cabezas-Wallscheid and Andreas Trumpp, Pia Sommerkamp could show that alternative polyadenylation (APA) is a novel molecular control mechanism used by hematopoietic stem cells (HSC) to adapt their metabolic and proliferative activity to emergency situations. Her PhD work was published in Cell Stem Cell (2020) and in Scientific Reports (2019).

A team of researchers around Pia Sommerkamp, who carried out her PhD thesis in the HI-STEM lab and now continues as a Postdoc, now reports alternative polyadenylation (APA) as a new layer of gene regulation. In their study, the team, which involved colleagues at the Max-Planck Institute in Freiburg and at Heidelberg University Hospital, reports APA as a new, so far unrecognized, layer of regulation of HSCs active during homeostasis and in response to emergency situations such as inflammation.

APA is a process that mediates selection of polyadenylation sites in mRNAs. It thereby regulates RNA/protein isoform expression and the length of the untranslated region of the mRNA (3’ UTR). Our study now demonstrates that the RNA regulatory mechanism APA is dynamically regulated within the hematopoietic stem cell and progenitor compartment. We could show that unperturbed APA is essential for proper HSC function. Using a novel sequencing approach to characterize the 3’ UTR in a genome-wide manner, it was possible to determine alternative polyadenylation landscapes (“APAomes”) in resting and activated HSCs, revealing distinct APA profiles and 3’ UTR length patterns. In addition, we show that metabolic reprogramming by APA is a prerequisite for HSC function in emergency situations. In the future, we will investigate whether APA regulation is also active in cancer stem cells, e.g. in leukemia, in order to evaluate possible ways to specifically interfere with this regulation in disease.

The work, which was published in Cell Stem Cell, was co-supervised by Andreas Trumpp from HI-STEM/DKFZ and Nina Cabezas-Wallscheid, HI-STEM Alumni and now a junior group leader at the Max-Planck-Institute of Immunobiology.

Read more:

  • Original Publication: Pia Sommerkamp, Sandro Altamura, Simon Renders, Andreas Narr, Luisa Ladel, Petra Zeisberger, Paula Leonie Eiben, Malak Fawaz, Michael A. Rieger, Nina Cabezas-Wallscheid und Andreas Trumpp: Differential alternative polyadenylation landscapes mediate hematopoietic stem cell activation and regulate glutamin metabolism.Cell Stem Cell 2020, DOI: 10.1016/j.stem.2020.03.003
  • DKFZ Press Release (German Version)
Lung metastasis in a breast cancer patient: the arrows indicate fibroblasts (brown) that communicate with metastatic cancer cells. Cell nuclei are stained blue. © Oskarsson, DKFZ/HI-STEM

In order to colonize other organs and grow into metastases, tumor cells that detach from the parent tumor need to manipulate their new microenvironment and create a 'metastatic niche'. Maren Pein and colleagues from the Oskarsson lab within HI-STEM and DKFZ have now discovered that disseminated breast cancer cells evoke phenotypic changes in lung fibroblasts to promote metastasis. This discovery, which is based on a collaboration with clinical partners at the National Center for Tumor Diseases (NCT) and the University Hospital in Heidelberg, plays a key role in better understanding how these dangerous metastases arise.

Read more:

Subcategories